These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30156318)

  • 21. Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease. Author's reply.
    Kamada Y; Miyoshi E
    Liver Int; 2015 Aug; 35(8):2062. PubMed ID: 25809239
    [No Abstract]   [Full Text] [Related]  

  • 22. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
    Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
    Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease.
    Gómez de la Cuesta S; Aller de la Fuente R; Tafur Sánchez C; Izaola O; García Sánchez C; Mora N; González Hernández JM; de Luis Román D
    Rev Esp Enferm Dig; 2018 May; 110(5):292-298. PubMed ID: 29338271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to letter to the editor by Kawada on "Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke".
    Parikh NS; Gutierrez J
    J Neurol Sci; 2020 Jan; 408():116574. PubMed ID: 31732172
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials.
    Pandey S
    Hepatology; 2020 Feb; 71(2):763-764. PubMed ID: 31393627
    [No Abstract]   [Full Text] [Related]  

  • 28. Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.
    Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Pai RK; Yerian L; Khiyami A; Sourianarayanane A; Sargent R; Hawkins C; Dasarathy S; McCullough AJ
    Dig Dis Sci; 2015 Jun; 60(6):1825-31. PubMed ID: 25708897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
    Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
    Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Harrison SA; Abdelmalek MF; Caldwell S; Shiffman ML; Diehl AM; Ghalib R; Lawitz EJ; Rockey DC; Schall RA; Jia C; McColgan BJ; McHutchison JG; Subramanian GM; Myers RP; Younossi Z; Ratziu V; Muir AJ; Afdhal NH; Goodman Z; Bosch J; Sanyal AJ;
    Gastroenterology; 2018 Oct; 155(4):1140-1153. PubMed ID: 29990488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Lee SM; Jun DW
    Clin Nutr; 2018 Apr; 37(2):759. PubMed ID: 29366517
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Jun DW; Lee S
    Clin Nutr; 2018 Jun; 37(3):1090. PubMed ID: 29478888
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease.
    Kawada T
    J Neurol Sci; 2020 Jan; 408():116575. PubMed ID: 31727327
    [No Abstract]   [Full Text] [Related]  

  • 35. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
    Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
    Stine JG; Rinella ME
    Am J Gastroenterol; 2017 May; 112(5):752-754. PubMed ID: 28469217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Cansanção K; Silva Monteiro L; Carvalho Leite N; Dávalos A; Tavares do Carmo MDG; Arantes Ferreira Peres W
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey.
    Shen H; Peng JL; Tayarachakul S; Liangpunsakul S
    J Investig Med; 2017 Jan; 65(1):43-48. PubMed ID: 27634642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
    Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.